Novanta Inc.

Informe acción NasdaqGS:NOVT

Capitalización de mercado: US$4.5b

Novanta Dirección

Dirección controles de criterios 4/4

El CEO de Novanta es Matthijs Glastra , nombrado en Sep 2016, tiene una permanencia de 8.75 años. compensación anual total es $8.78M, compuesta por 9.4% salario y 90.6% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.39% de las acciones de la empresa, por valor de $17.65M. La antigüedad media del equipo directivo y de la junta directiva es de 2.9 años y 4.1 años, respectivamente.

Información clave

Matthijs Glastra

Chief Executive Officer (CEO)

US$8.8m

Compensación total

Porcentaje del salario del CEO9.42%
Permanencia del CEO8.8yrs
Participación del CEO0.4%
Permanencia media de la dirección2.9yrs
Promedio de permanencia en la Junta Directiva4.1yrs

Actualizaciones recientes de la dirección

Recent updates

Returns At Novanta (NASDAQ:NOVT) Appear To Be Weighed Down

May 20
Returns At Novanta (NASDAQ:NOVT) Appear To Be Weighed Down

Here's Why Novanta (NASDAQ:NOVT) Can Manage Its Debt Responsibly

May 03
Here's Why Novanta (NASDAQ:NOVT) Can Manage Its Debt Responsibly

Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?

Apr 19
Should You Think About Buying Novanta Inc. (NASDAQ:NOVT) Now?

Novanta: A Trusted Yet Premium Technology Partner

Apr 06

Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors

Apr 05
Novanta Inc.'s (NASDAQ:NOVT) Stock Retreats 27% But Earnings Haven't Escaped The Attention Of Investors

There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings

Mar 05
There May Be Some Bright Spots In Novanta's (NASDAQ:NOVT) Earnings

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 09
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Is Novanta (NASDAQ:NOVT) A Risky Investment?

Jan 24
Is Novanta (NASDAQ:NOVT) A Risky Investment?

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?

Jan 07
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$151?

Novanta: Delayed Recovery And Prolonged Struggles Ahead, Downgrade To Sell

Jan 01

Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Dec 21
Novanta Inc.'s (NASDAQ:NOVT) Business Is Yet to Catch Up With Its Share Price

Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

Oct 15
Novanta (NASDAQ:NOVT) May Have Issues Allocating Its Capital

What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Sep 12
What You Can Learn From Novanta Inc.'s (NASDAQ:NOVT) P/S

Novanta Inc.: Overpriced In A Weak Demand Market. Here's Why It's A Hold

Sep 02
author-image

Innovative Medical Devices And Tactical Acquisitions Poised To Accelerate Company Growth

Focusing on medical devices with new products might significantly boost future revenue through innovation, aiming for notable revenue from new launches by 2025.

Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Aug 24
Is It Too Late To Consider Buying Novanta Inc. (NASDAQ:NOVT)?

Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Aug 02
Novanta Inc.'s (NASDAQ:NOVT) Intrinsic Value Is Potentially 21% Below Its Share Price

Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Jun 22
Novanta (NASDAQ:NOVT) Might Be Having Difficulty Using Its Capital Effectively

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

May 30
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

May 08
Investors Still Waiting For A Pull Back In Novanta Inc. (NASDAQ:NOVT)

Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Feb 24
Novanta (NASDAQ:NOVT) Has Some Way To Go To Become A Multi-Bagger

Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Feb 05
Does Novanta (NASDAQ:NOVT) Have A Healthy Balance Sheet?

Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Dec 29
Getting In Cheap On Novanta Inc. (NASDAQ:NOVT) Is Unlikely

Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Nov 20
Why Novanta Inc. (NASDAQ:NOVT) Could Be Worth Watching

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Nov 01
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Oct 19
Does This Valuation Of Novanta Inc. (NASDAQ:NOVT) Imply Investors Are Overpaying?

Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Sep 21
Novanta (NASDAQ:NOVT) Seems To Use Debt Quite Sensibly

Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

Sep 06
Return Trends At Novanta (NASDAQ:NOVT) Aren't Appealing

What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Aug 19
What Does Novanta Inc.'s (NASDAQ:NOVT) Share Price Indicate?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Jul 16
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

Jun 06
Slowing Rates Of Return At Novanta (NASDAQ:NOVT) Leave Little Room For Excitement

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

May 16
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Reasonably Well

Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Apr 13
Should You Investigate Novanta Inc. (NASDAQ:NOVT) At US$156?

Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Mar 29
Here's Why We Think Novanta (NASDAQ:NOVT) Is Well Worth Watching

Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

Feb 27
Investors Met With Slowing Returns on Capital At Novanta (NASDAQ:NOVT)

These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Feb 12
These 4 Measures Indicate That Novanta (NASDAQ:NOVT) Is Using Debt Safely

Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

Jan 12
Is Novanta Inc. (NASDAQ:NOVT) Potentially Undervalued?

We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Dec 28
We Ran A Stock Scan For Earnings Growth And Novanta (NASDAQ:NOVT) Passed With Ease

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Matthijs Glastra en comparación con los beneficios de Novanta?
FechaCompensación totalSalarioIngresos de la empresa
Mar 28 2025n/an/a

US$71m

Dec 31 2024US$9mUS$826k

US$64m

Sep 27 2024n/an/a

US$60m

Jun 28 2024n/an/a

US$62m

Mar 29 2024n/an/a

US$69m

Dec 31 2023US$8mUS$784k

US$73m

Sep 29 2023n/an/a

US$76m

Jun 30 2023n/an/a

US$77m

Mar 31 2023n/an/a

US$73m

Dec 31 2022US$7mUS$731k

US$74m

Sep 30 2022n/an/a

US$73m

Jul 01 2022n/an/a

US$64m

Apr 01 2022n/an/a

US$58m

Dec 31 2021US$12mUS$690k

US$50m

Oct 01 2021n/an/a

US$49m

Jul 02 2021n/an/a

US$44m

Apr 02 2021n/an/a

US$44m

Dec 31 2020US$5mUS$625k

US$45m

Oct 02 2020n/an/a

US$41m

Jul 03 2020n/an/a

US$42m

Apr 03 2020n/an/a

US$40m

Dec 31 2019US$4mUS$640k

US$41m

Sep 27 2019n/an/a

US$43m

Jun 28 2019n/an/a

US$56m

Mar 29 2019n/an/a

US$57m

Dec 31 2018US$4mUS$581k

US$51m

Compensación vs. Mercado: La compensación total ($USD8.78M) de Matthijs está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD7.51M).

Compensación vs. Ingresos: La compensación de Matthijs ha sido consistente con los resultados de la empresa en el último año.


CEO

Matthijs Glastra (56 yo)

8.8yrs
Permanencia
US$8,776,305
Compensación

Mr. Matthijs Glastra serves as Independent Director at IDEX Corporation from February 21, 2025. He has been the Chief Executive Officer and Director of Novanta Inc. since September 1, 2016 and serves as it...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Matthijs Glastra
CEO & Chairman of the Board8.8yrsUS$8.78m0.39%
$ 17.7m
Robert Buckley
Chief Financial Officer14.3yrsUS$3.91m0.35%
$ 16.1m
Michele Michele Welsh
General Counsel & Corporate Secretary2.9yrsUS$1.39m0.0041%
$ 186.8k
John Burke
Chief Accounting Officer & Corporate Controllerless than a yearsin datos0.022%
$ 997.9k
Ray Nash
Corporate Finance Leader & IRno datasin datossin datos
Sarah Betadam
Chief Information Officer & Chief Information Security Officer4.4yrssin datossin datos
Nissia Sabri
Senior Vice President of Corporate Development1.6yrssin datossin datos
Liam Weston
Chief Human Resources Officerless than a yearsin datossin datos
Chuck Ravetto
Co-Chief Operating Officer of Automation Enabling Technologies3.2yrssin datos0.037%
$ 1.7m
Anna Fain
Senior Vice President of Leadership Development and Diversity2.1yrssin datossin datos
John Lesica
Co-Chief Operating Officer of Medical Solutionsless than a yearsin datossin datos
Heinrich Dreyer
Group President of Medical Solutions7.2yrssin datossin datos
2.9yrs
Permanencia media
51yo
Promedio de edad

Equipo directivo experimentado: El equipo directivo de NOVT se considera experimentado (2.9 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Matthijs Glastra
CEO & Chairman of the Board8.8yrsUS$8.78m0.39%
$ 17.7m
Stephen Bershad
Chairman Emeritus4.1yrsUS$233.48ksin datos
Barbara Hulit
Independent Director2.9yrsUS$277.15k0.0060%
$ 271.3k
Mary Ladone
Independent Directorless than a yearUS$126.63ksin datos
Darlene J. Solomon
Independent Director3yrsUS$277.45k0.0062%
$ 279.9k
Lonny Carpenter
Independent Lead Director7.1yrsUS$317.45k0.013%
$ 571.2k
Frank Wilson
Independent Director4.1yrsUS$302.45k0.0073%
$ 331.3k
Thomas Secor
Independent Director13yrsUS$282.45k0.0042%
$ 189.0k
Robert Johnson
Independent Director1.1yrsUS$173.47k0.0023%
$ 103.2k
Maxine Mauricio
Independent Director5.1yrsUS$282.45k0.0090%
$ 407.2k
4.1yrs
Permanencia media
57yo
Promedio de edad

Junta con experiencia: La junta directiva de NOVT se considera experimentada (4.1 años de antigüedad promedio).


Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2025/06/06 21:09
Precio de las acciones al final del día2025/06/06 00:00
Beneficios2025/03/28
Ingresos anuales2024/12/31

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
Principales avances10 años
  • Anuncios de empresas

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al equipo de talla mundial que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Novanta Inc. está cubierta por 10 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Robert MasonBaird
Ishan MajumdarBaptista Research
Andrew BuscagliaBerenberg